期刊文献+

The chemokine CCL17 is a novel therapeutic target for cardiovascular aging

原文传递
导出
摘要 Dear Editor,Aging results in higher susceptibility to age-related disease,especially cardiovascular disease,which has become a public health priority.1,2 Recent studies have progressively unraveled the critical role of vasculature as a gatekeeper of life-span and health-span.3 In this light,vascular rejuvenation is geroprotective.The circulating proteomic signature is tightly related to aging and aging-induced vascular diseases,4 but drugs targeting circulating proteins are not available.
出处 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2023年第5期2068-2071,共4页 信号转导与靶向治疗(英文)
基金 supported by the National Natural Science Foundation of China (82200437,81970426) CAMS Innovation Fund for Medical Sciences (CIFMS) (2021-I2M-1-003) National Key Research and Development Program of China (2022YFC2703100) Shanghai Clinical Research Center for Interventional Medicine (19MC1910300) National High Level Hospital Clinical Research Funding 2022-PUMCH-B-098.
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部